Related Experiment Video
Updated: Jul 24, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease
Insights
Chlamydia pneumoniae infection shows a strong immune response link to coronary heart disease (CHD) in males. This suggests Chlamydia
Area of Science:
- Immunology
- Cardiovascular Medicine
- Infectious Diseases
Background:
- Coronary atherosclerosis is a significant health concern.
- The role of Chlamydia pneumoniae infection in cardiovascular disease is under investigation.
- Understanding immune responses to Chlamydia may elucidate disease mechanisms.
Purpose of the Study:
- To investigate the association between Chlamydia pneumoniae infection and coronary atherosclerosis.
- To analyze cell-mediated and humoral immune responses to Chlamydia in patients with and without coronary heart disease.
Main Methods:
- Studied 93 patients with coronary heart disease and 115 controls.
- Assessed cell-mediated immunity via lymphocyte proliferation assays to C. pneumoniae and C. trachomatis antigens.
- Measured Chlamydia-specific antibodies (IgG, IgA) using microimmunofluorescence.
Main Results:
- Elevated IgG and IgA antibodies and strong lymphocyte proliferation to C. pneumoniae were associated with coronary heart disease in males.
- Male patients with coronary heart disease exhibited robust cell-mediated responses to both C. pneumoniae and C. trachomatis.
- Females with coronary heart disease showed stronger cell-mediated responses to C. pneumoniae than C. trachomatis, similar to controls.
Conclusions:
- Marked cell-mediated and humoral immunity to C. pneumoniae in males with coronary heart disease suggests a contributing role in pathogenesis.
- Immune mechanisms triggered by Chlamydia may be a factor in male coronary atherosclerosis.
- Chlamydia-specific cell-mediated responses appear to be induced by cross-reactive antigens among Chlamydia species.
Aims:
To clarify the relationship of Chlamydia pneumoniae infection and coronary atherosclerosis we studied cell-mediated and humoral immune responses to Chlamydia in 93 patients with angiographically confirmed coronary heart disease and in 115 controls without angiographically demonstrable lesions.
Methods And Results:
Cell-mediated responses were analysed by measuring lymphocyte proliferative reactivity to whole elementary body antigens of C. pneumoniae. Control antigens included C. trachomatis and purified protein derivative of tuberculin. Chlamydia-specific antibodies were measured using microimmunofluorescence assay. Marked C. pneumoniae-specific immune reactivity, demonstrated by the high incidence of elevated IgG and IgA antibodies and strong lymphocyte proliferative response, was associated with coronary heart disease in male but not in female patients or controls. In male patients, the cell-mediated responses were strong to C. pneumoniae (median stimulation index 9,6) and to C. trachomatis (stimulation index 6,9). The females with coronary heart disease showed significantly stronger cell-mediated responses to C. pneumoniae (stimulation index 6,5) than to C. trachomatis (3,8; P < 0.001) and were comparable to the controls.
Conclusion:
Marked cell-mediated and humoral immunity to C. pneumoniae in males with coronary heart disease suggest that the immune mechanisms triggered by Chlamydia are a possible contributing factor in the disease pathogenesis of coronary atherosclerosis in males. The Chlamydia-specific cell-mediated responses seem to be predominantly induced by antigenic structures that are similar among different Chlamydia-species.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

